Six notes:
1. Net sales of $1.9 billion represent a 3.9% increase year-over-year, according to a news release.
2. Highlights of the quarter include plans to acquire OrthoGrid Systems, forming a partnership with CBRE Group for ASC growth and a partnership with RevelAiHealth.
3. Net earnings in the second quarter were $242.8 million, compared to $209.6 million in the same period last year.
4. Knee sales were $801.1 million, a 3.9% year-over-year increase, and hip sales grew 0.4% with $506.5 million in sales.
5. Sports medicine, extremities, trauma, craniomaxillofacial and thoracic sales were $469.5 million, a 6.1% increase year-over-year.
6. Zimmer Biomet lowered its full-year guidance and now expects 2024 revenue to grow 4% to 5%. Previously that growth was projected at 4.5% to 5.5%.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
